Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Smoore International Holdings Limited
  6. News
  7. Summary
    6969   KYG8245V1023

SMOORE INTERNATIONAL HOLDINGS LIMITED

(6969)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Robust JD Health shines on Hong Kong debut with 56% rise

12/07/2020 | 08:41pm EDT
FILE PHOTO: HKEX logo is seen in the financial Central district in Hong Kong

HONG KONG, Dec 8 (Reuters) - JD Health International Inc made one of the strongest public market debuts for a major Hong Kong initial public offering on Tuesday, with its shares closing up 56%.

The rise gives JD Health, which specializes in online medical consultation and pharmaceutical sales, a market value of more than $40 billion.

JD Health, a subsidiary of ecommerce giant JD.com , was among the platforms offering consultation for COVID-19 symptoms at the height of China's coronavirus outbreak this year.

Kingston Securities executive director of research Dickie Wong said such a large market capitalisation should see JD Health fast-tracked into the Shanghai Hong Kong Stock Connect and Hang Seng technology index.

"Investors are thinking they don't want to wait to buy," he said. "Once the stock moves into the tech index, then index funds have to buy it no matter what they think of the company so investors are taking advantage of the likely move now."

JD Health sold shares at HK$70.58 each in its IPO, raising $3.48 billion and giving it an initial valuation of $29 billion.

The float took Hong Kong's 2020 IPO proceeds beyond $25 billion from over 100 deals, on track for the best year in a decade, Refinitiv data showed. Including secondary listings, the total stands at $39.1 billion.

Tuesday's IPO was Hong Kong's largest this year, followed by China Bohai Bank Co Ltd's $2.05 billion listing in July, and bankers expect more activity in December.

JD Health stock opened at HK$94.50 and reached $HK123.9, before closing at $HK$110, a rise of nearly 56% compared to its issue price which made it the fourth best performing IPO worth more than $1 billion in Hong Kong.

Shares in the now delisted alibaba.com closed 142% higher on its first day of trade in 2007, while Smoore International Holdings gained 139% when it listed in July and China Literature closed 89% above its issue price on its debut in 2017, Refinitiv data showed.

JD Health's shares outshone the broader Hong Kong market on Tuesday, with the Hang Seng Index closing down 0.76%, its second day in negative territory.

However, JD Health's rapid rise may make it vulnerable to a swift sell-off, Everbright Sun Hung Kai analyst Kenny Ng said.

"JD Health provides a good opportunity for profit-taking in the short term if its share price is above $HK100 since IPO investors have already got around 40% return," he said.

PANDEMIC IMPACT

The pandemic has had a "revolutionary impact" on healthcare as both patients and doctors are now more willing to seek and provide treatment over the internet, Chief Executive Xin Lijun told reporters at a briefing in Beijing.

JD Health's IPO prospectus showed a 36% on-year growth in annual active users to 72.5 million at the end of June.

Xin said JD Health might spend some of the IPO funds buying brick-and-mortar pharmacies.

"Investment is needed to bring more pharmacies and hospitals online into our system," he said. (Reporting by Scott Murdoch in Hong Kong and Sophie Yu in Beijing; Additional reporting by Donny Kwok in Hong Kong; Editing by Kim Coghill, Christopher Cushing and Alexander Smith)


© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
ALIBABA GROUP HOLDING LIMITED -1.19% 195.19 Delayed Quote.-16.13%
CHINA EVERBRIGHT LIMITED 1.66% 8.55 End-of-day quote.-17.63%
CHINA LITERATURE LIMITED -2.83% 72 End-of-day quote.18.32%
HANG SENG -1.32% 25935.58 Real-time Quote.-4.76%
SMOORE INTERNATIONAL HOLDINGS LIMITED -4.02% 33.4 End-of-day quote.-44.19%
SUN HUNG KAI & CO. LIMITED 0.76% 4 End-of-day quote.22.32%
SUN HUNG KAI PROPERTIES LIMITED -1.24% 111.3 End-of-day quote.11.30%
All news about SMOORE INTERNATIONAL HOLDINGS LIMITED
07/13SMOORE INTERNATIONAL : Grants Stock Options to Employees
MT
07/10Certain Ordinary Shares of Smoore International Holdings Limited are subject ..
CI
07/08SMOORE INTERNATIONAL : Expects Adjusted Net Profit to Surge Up To 139% in Januar..
MT
07/07Smoore International Holdings Limited Provides Consolidated Earnings Guidance..
CI
07/01SMOORE INTERNATIONAL : VAPORESSO Parent Company SMOORE International Listed on F..
AQ
05/27EQS-NEWS : Smoore International Announces Two Year Extension of Agreement with A..
DJ
05/27Smoore International Holdings Limited Approves Final Dividend for the Year En..
CI
04/22SMOORE INTERNATIONAL : Financial update for the period ended 31 march 2021
PU
04/22Smoore International Holdings Limited Announces Unaudited Earnings Results fo..
CI
04/09SMOORE INTERNATIONAL : Vaporesso's New Eco-Friendly Design Receives Red Dot Awar..
AQ
More news
Financials
Sales 2021 14 655 M 2 268 M 2 268 M
Net income 2021 5 407 M 837 M 837 M
Net cash 2021 13 238 M 2 049 M 2 049 M
P/E ratio 2021 29,8x
Yield 2021 1,22%
Capitalization 166 B 25 646 M 25 647 M
EV / Sales 2021 10,4x
EV / Sales 2022 7,40x
Nbr of Employees 14 273
Free-Float 29,3%
Chart SMOORE INTERNATIONAL HOLDINGS LIMITED
Duration : Period :
Smoore International Holdings Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SMOORE INTERNATIONAL HOLDINGS LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 13
Last Close Price 27,77 CNY
Average target price 67,32 CNY
Spread / Average Target 142%
EPS Revisions
Managers and Directors
Zhi Ping Chen Chairman & Chief Executive Officer
Gui Sheng Wang CFO, Executive Director & Joint Secretary
Chun Hua Luo General Manager-Operation Department
Jie Liu Independent Non-Executive Director
Siu Wing Yim Independent Non-Executive Director